Dr. Pamela Weiss on Juvenile SpA 10-20% of AS pts have symptom once before 18 Only 38% of patients complained of back pain @RheumNow #RNL2022 https://t.co/Ydd58g7V62

#RNL2022 Spondyloarthritis Faculty Panel Q&A with Drs. Scher, Mease and Weiss. https://t.co/EL4s2jDegb

Difference between Juvenile versus adult onset SpA. Pamela Weiss @RheumNow #Rnl2022 https://t.co/WPO673jQi3

#clinicalPearl Fun fact Gut microbiome in mice metabolizes #methotrexate but if given #antibiotics it is not or less metabolized. Good or bad for human studies? Dunno 🤷‍♂️ #RNL2022 @RheumNow https://t.co/FmdZpJ3dzj

Dr. Jose Scher on gut microbiome in spondyloarthritis Decreased diversity in AxSpA gut microbiome associated with worse disease activity Decreased diversity in PsA gut microbiome resembles IBD dysbiosis @RheumNow #RNL2022 https://t.co/30ntxPRSif

ClinicalPearl Axial #PsA is often LESS symptomatic than #ankylosing #spondylitis, often with active peripheral PsA & less are HLAB27 #RNL2022 @RheumNow Phil Mease’s great talk https://t.co/JIETaXawBd

Short chain fatty acid metabolites can help prevent IBD and improve inflammatory arthritis @RheumNow #RNL2022 https://t.co/2a4cUIdEat

High fiber diet can increase short chain fatty acids and decreased pro-arthritogenic cytokines @RheumNow #RNL2022 https://t.co/L1NQoSAAWS

Dr. Mease reviews axial disease in PsA. Here are my pearls. 💎It is not the same as AxSpA 💎Can be asymptomatic 💎sacroiliitis can by asymmetrical 💎may not appear in consecutive vertebrae 💎may not follow ALL #RNL2022 @RheumNow https://t.co/tuXTORp9lp

Important pearls on Psoriatic arthritis from #PhilipMease at #RNL2022: ☝️axial disease may present late in the course of PsA vs in early stages if the disease in ankylosis spondylitis ☝️can be asymptomatic (prevalence of inflam back pain 45% vs AS) @RheumNow https://t.co/uIdvMGKrAH

Dr. Mease explores the GRAPPA evidence table for PsA treatment recommendations in axial disease. #RNL2022 @RheumNow https://t.co/gVv2W7OnMM

Dr. Philip Mease on PsA Axial Disease vs. AS Can be asymptomatic, unilateral, more peripheral arthritis @RheumNow #RNL2022 https://t.co/lExb7n9xWR

A dilemma at the ‘SPA’ what to use in axial PsA beyond TNFi? IL17, JAKi, Another TNFi. What about IL23i? #RNL2022 @RheumNow presented by Phil Mease https://t.co/Db68lqCEfJ

Medications that worked for axial involvement in PsA patients. Philip Mease @RheumNow #Rnl2022 https://t.co/wJYnyNuhbd

One shortcoming in determining axial disease activity is the BASDAI itself. And yet, this study by Dr. @AlexisOgdie shows that the BASDAI scores were similar in those w and w/o axial disease in PsA. Dr. Mease. And yet not all drugs work equally in PsA/axSpA. #RNL2022 @RheumNow https://t.co/h1PYfNgEV3